Skip to main content
. 2021 May 27;14:575–583. doi: 10.2147/JAA.S312123

Figure 3.

Figure 3

Peripheral blood eosinophils over the 12 months of dupilumab. Each line with dots represents a patient eosinophil count at each follow-up visit. **p<0.01.

Abbreviation: ns, non-significant.